| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/2009 | US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 04/23/2009 | US20090104073 Prion deactivating composition and methods of using same |
| 04/23/2009 | DE102007050165A1 Stabilisierung von hydrophoben Proteintherapeutika Stabilization of hydrophobic protein therapeutics |
| 04/23/2009 | CA2741094A1 Methods for treatment of thiol-containing compound deficient conditions |
| 04/23/2009 | CA2740882A1 Use of ps20/wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | CA2737616A1 Sterile autologous, allogenic or xenogenic implant and the method of its production |
| 04/23/2009 | CA2703720A1 Improved antitumoral treatments |
| 04/23/2009 | CA2703024A1 Improved antitumoral treatments |
| 04/23/2009 | CA2702970A1 Manufacture, compositions and uses of coagulation factor viia modulator |
| 04/23/2009 | CA2702892A1 An orally administerable solid pharmaceutical composition and a process thereof |
| 04/23/2009 | CA2702740A1 Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
| 04/23/2009 | CA2702686A1 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 04/23/2009 | CA2702655A1 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 04/23/2009 | CA2702494A1 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 04/23/2009 | CA2702442A1 Peptide compounds for treating obesity and insulin resistance |
| 04/23/2009 | CA2702378A1 Novel patient subgroups for thrombolysis |
| 04/23/2009 | CA2702363A1 Human factor ix variants with an extended half life |
| 04/23/2009 | CA2701329A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | CA2700729A1 Therapeutic agent for vitiligo and method of accelerating pigmentation |
| 04/23/2009 | CA2700168A1 Patch with hydrophilic adhesive |
| 04/23/2009 | CA2699075A1 Use of a peptide as a therapeutic agent |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050761A1 Galactosylated peptides, their preparation and use in autoimmune diseases diagnosis |
| 04/22/2009 | EP2050468A1 Agent for treatment of cerebral ischemic diseases |
| 04/22/2009 | EP2050464A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 04/22/2009 | EP2050462A1 Improved treatment of stroke patients |
| 04/22/2009 | EP2050461A1 Peptides based on the sequence of human lactoferrin and their use |
| 04/22/2009 | EP2050460A1 PYY and agonists thereof for modification of feeding behaviour |
| 04/22/2009 | EP2050459A1 Prophylactic or therapeutic agent for viral disease |
| 04/22/2009 | EP2050458A1 IL24 for inducing hyperproliferative or autoimmune cell death |
| 04/22/2009 | EP2050455A1 Compounds leading to an increase of the IL-12/IL-10 ratio and their use for therapy of infectious and proliferative diseases |
| 04/22/2009 | EP2050444A1 Fatigue-reducing agent |
| 04/22/2009 | EP2049899A2 Methods to prevent and treat diseases |
| 04/22/2009 | EP2049893A2 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 04/22/2009 | EP2049691A2 Crohn disease susceptibility gene |
| 04/22/2009 | EP2049661A2 Long half-life recombinant butyrylcholinesterase |
| 04/22/2009 | EP2049568A2 Erbb receptor-derived peptide fragments |
| 04/22/2009 | EP2049562A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 04/22/2009 | EP2049560A1 Process for preparing particles of proteinaceous material |
| 04/22/2009 | EP2049524A2 Iap inhibitors |
| 04/22/2009 | EP2049151A2 Methods and compositions for the treatment of cancer |
| 04/22/2009 | EP2049150A2 Recombinant ou transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated forms |
| 04/22/2009 | EP2049149A2 Pegylated extended insulins |
| 04/22/2009 | EP2049148A1 A stable liquid formulation of human growth hormone |
| 04/22/2009 | EP2049147A2 Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy |
| 04/22/2009 | EP2049146A2 Use of proteins of the sdf-1-family for for improvement of axonal plasticity or for axonal regeneration following lesions |
| 04/22/2009 | EP2049145A2 Pdgf-biomatrix compositions and methods for treating rotator cuff injuries |
| 04/22/2009 | EP2049144A2 Glycosylation of peptides via o-linked glycosylation sequences |
| 04/22/2009 | EP2049143A1 Improved antibacterial antisense oligonucleotide and method |
| 04/22/2009 | EP2049142A1 Caspofungin formulations |
| 04/22/2009 | EP2049141A1 Treatment for intimal hyperplasia and related conditions |
| 04/22/2009 | EP2049140A2 Kit and methods of treatment of an intervertebral disc |
| 04/22/2009 | EP2049139A2 Treatment of ras-expressing tumors |
| 04/22/2009 | EP2049138A2 Clc channel ligand |
| 04/22/2009 | EP2049137A2 Salicylanilides enhance oral delivery of therapeutic peptides |
| 04/22/2009 | EP2049136A1 Mitochondria-targeted antioxidants |
| 04/22/2009 | EP2049135A2 Lactoferrin as a radioprotective agent |
| 04/22/2009 | EP2049126A2 Liposome treatment of viral infections |
| 04/22/2009 | EP2049091A1 Casein complexes |
| 04/22/2009 | EP2049085A1 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same |
| 04/22/2009 | EP2049040A2 Whole blood-derived coagulum device for treating bone defects |
| 04/22/2009 | EP2048969A1 Fractions of whey permeate and its use for the prevention and therapy of type 2 diabetes and the metabolic syndrome |
| 04/22/2009 | EP2048955A2 Targeted gene delivery for dendritic cell vaccination |
| 04/22/2009 | EP2002842A9 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 04/22/2009 | EP1998789A4 Biomarkers for amyotrophic lateral sclerosis and methods using the same |
| 04/22/2009 | EP1988913B1 G-csf liquid formulation |
| 04/22/2009 | EP1951319A4 Chimeric immunoreceptor useful in treating human cancers |
| 04/22/2009 | EP1819729B1 Method for producing carboxy-terminal amidified peptides |
| 04/22/2009 | EP1781697B1 Novel carbamylated epo and method for its production |
| 04/22/2009 | EP1718328B1 Use of factor xiii for stimulating the perfusion of ischemic tissue |
| 04/22/2009 | EP1715883B1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/22/2009 | EP1572968B1 Lutzomyia longipalpis polypeptides and methods of use |
| 04/22/2009 | EP1568768B1 PROTEIN BINDING TO Akt2 |
| 04/22/2009 | EP1554382B1 Gpr54 knock-out mammals and screening methods using them |
| 04/22/2009 | EP1515704B1 Microcapsules for the delayed, controlled release of perindopril |
| 04/22/2009 | EP1468014B1 Compositions and methods for WT1 specific immunotherapy |
| 04/22/2009 | EP1395648B1 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 04/22/2009 | EP1379873B1 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 04/22/2009 | EP1317419B1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/22/2009 | EP1299727B1 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/22/2009 | EP1214088B1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 04/22/2009 | EP1146890B1 Buccal delivery system for proteinaceous medicaments |
| 04/22/2009 | EP1090039B1 Peptide composition as immunogen for the treatment of allergy |
| 04/22/2009 | EP1089757B1 Hla binding peptides and their uses |
| 04/22/2009 | EP0959897B1 Method of regulating nitric oxide production |
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | EP0882067B2 Methods of treating vascular disease with tnf antagonists |
| 04/22/2009 | EP0842948B1 ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME |
| 04/22/2009 | EP0635068B2 Amplification of human mdm2 gene in human tumors |
| 04/22/2009 | CN101415730A Compositions and methods of use for antibodies of c-Met |
| 04/22/2009 | CN101415727A Binder for C-reactive protein |
| 04/22/2009 | CN101415724A Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 04/22/2009 | CN101415461A Adiponectin for treatment of various disorders |
| 04/22/2009 | CN101415439A Glp-1 agonists, compositions, methods and uses |
| 04/22/2009 | CN101415435A Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 04/22/2009 | CN101415434A Methods and compositions for the treatment of B cell lymphomas and other cancers |
| 04/22/2009 | CN101415406A Calcium phosphate complex in acid containing chewing gum |
| 04/22/2009 | CN101412995A Polyethyleneglycol modified aprotinin and preparation thereof |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |